Detalles de la búsqueda
1.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
N Engl J Med
; 382(23): 2197-2206, 2020 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469184
2.
High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience.
Can Urol Assoc J
; 18(3): E73-E79, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010229
3.
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
Eur Urol
; 83(1): 15-26, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055895
4.
Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.
Can Urol Assoc J
; 17(10): 326-336, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37494316
5.
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial.
J Clin Oncol
; 41(22): 3839-3850, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290035
6.
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.
Can Urol Assoc J
; 16(10): 321-332, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240332
7.
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study.
Eur J Cancer
; 170: 73-84, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598359
8.
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study.
Eur Urol
; 82(1): 22-30, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397952
9.
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).
Clin Cancer Res
; 28(8): 1518-1530, 2022 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35091440
10.
Corrigendum to "Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study" [Eur Urol 83 (2023) 15-26].
Eur Urol
; 83(3): e87, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528479
11.
Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.
Can Urol Assoc J
; 16(4): 132-143, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812730
12.
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 70(5): 724-731, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26965561
13.
Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma.
Clin Genitourin Cancer
; 12(6): 440-6, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24787971
14.
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
Urol Oncol
; 32(4): 501-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24332646
Resultados
1 -
14
de 14
1
Próxima >
>>